Midterm outcomes of percutaneous endovascular treatment for below-the-knee chronic total occlusion

ZHAO Jing; JIA Xin

doi:10.3969/j.issn.2095-5227.2021.02.011

Volume 42 Issue 2

Feb. 2021

Turn off MathJax

Article Contents

Abstract

References

ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL > 2021 > 42(2): 177-181. > DOI: 10.3969/j.issn.2095-5227.2021.02.011

ZHAO Jing, JIA Xin. Midterm outcomes of percutaneous endovascular treatment for below-the-knee chronic total occlusion[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2021, 42(2): 177-181. DOI: 10.3969/j.issn.2095-5227.2021.02.011

Citation:

PDF (599 KB)

Midterm outcomes of percutaneous endovascular treatment for below-the-knee chronic total occlusion

ZHAO Jing^1, ,,
JIA Xin²

1.
Department of Peripheral Vascular, Shenyang Second Chinese Medicine Hospital, Shenyang 110101, Liaoning Province, China
2.
Department of Vascular Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China

More Information

Corresponding author:
ZHAO Jing. Email: 18040063436@163.com
Received Date: August 25, 2020
Available Online: October 18, 2021

Graphical Abstract

Abstract

Abstract

Background There are limited evidences regarding the clinical effect of percutaneous transluminal angioplasty (PTA) in the treatment of below-the-knee chronic total occlusion, and the key points of treatment remain unclear.
Objective To investigate the midterm clinical effect and key points of PTA in the treatment of below-the-knee chronic total occlusion.
Methods A retrospective analysis was performed for the clinical data about 18 patients with below-the-knee chronic total occlusion who were admitted to the department of peripheral vascular disease, Shenyang Second Hospital of Traditional Chinese Medicine from January 2019 to January 2020, and related data were analyzed, including the process of surgical treatment, clinical symptoms and signs before and after surgery, severity of ulcer and gangrene, auxiliary examination, and vascular patency.
Results Among the 18 patients, there were 10 male patients and 8 female patients, with a mean age of 65.5 ± 5.53 years, and all patients were followed up for 24 weeks after PTA. At 2 weeks after PTA treatment, 10 patients were cured, 5 had marked response, 2 had improvement, 1 had no change, and no patient had deterioration, with a response rate of 94.4%. After surgery, 15 patients achieved revascularization, an increase in skin temperature, and an improvement in ankle-brachial index, and the success rate of surgery was 83.3%. Nourishing vessels were established around the lesions for 2 patients, who had improved clinical symptoms. One patient experienced failure in revascularization and had no change in clinical symptoms, thus trans tibiofibular amputation was performed. Rutherford class and Wagner grade changed over time and decreased significantly after surgery (P＜0.05). Within 2-4 weeks after PTA, 2 patients achieved ulcer healing, and ulcers transformed into dry gangrene in 2 patients; within 4-8 weeks after PTA, 3 patients with clear amputation level underwent partial amputation of feet or toes (a second surgery was performed for 1 patient with dry gangrene) and achieved good incision healing and a reduction in amputation level. The limb salvage rate was 94.4%. The restenosis rate was 20% at 12 weeks after PTA, and secondary patency was obtained after PTA treatment again. At 12 and 24 weeks after surgery, the primary patency rate was both 80%, and the secondary patency rate was both 100%.
Conclusion PTA is a safe and effective method for the treatment of below-the-knee chronic total occlusion.

FullText(HTML)

References (26)

References

[1]	温志国,梁德安,李文明,等. 膝下动脉硬化闭塞症介入治疗[J]. 中国疗养医学,2018,27(11): 1185-1186.
[2]	Farber A,Eberhardt RT. The current state of critical limb ischemia:a systematic review[J]. JAMA Surg,2016,151(11): 1070-1077. doi: 10.1001/jamasurg.2016.2018
[3]	Norgren L,Hiatt WR,Dormandy JA,et al. Inter-society consensus for the management of peripheral arterial disease (TASC II)[J]. J Vasc Surg,2007,45(Suppl S): S5-S67.
[4]	陈艺,黄秋琴,向定成. 规范使用肠溶阿司匹林相关研究进展[J]. 解放军医学院学报,2019,40(10): 995-997. doi: 10.3969/j.issn.2095-5227.2019.10.020
[5]	Barnes JA,Eid MA,Creager MA,et al. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease[J]. Arterioscler Thromb Vasc Biol,2020,40(8): 1808-1817. doi: 10.1161/ATVBAHA.120.314595
[6]	Brazeau NF,Pinto EG,Harvey HB,et al. Critical limb ischemia:an update for interventional radiologists[J]. Diagn Interv Radiol,2013,19(2): 173-180.
[7]	纪东华. 膝下动脉腔内治疗新概念[J]. 中华血管外科杂志,2019,4(3): 135-137. doi: 10.3760/cma.j.issn.2096-1863.2019.03.002
[8]	田珂,常超. 经皮腔内血管成形术/支架植入术联合瑞舒伐他汀治疗下肢动脉硬化闭塞症远期疗效分析[J]. 中华实验外科杂志,2019,36(1): 175-176. doi: 10.3760/cma.j.issn.1001-9030.2019.01.058
[9]	European Working Group on Critical Limb Ischemia. Second European Consensus Document on chronic critical leg ischemia[J]. Eur J Vasc Surg,1992,6(Suppl A): 1-32.
[10]	Aboyans V,Desormais I,Lacroix P,et al. The general prognosis of patients with peripheral arterial disease differs according to the disease localization[J]. J Am Coll Cardiol,2010,55(9): 898-903. doi: 10.1016/j.jacc.2009.09.055
[11]	虞希祥,高秀仙,肖池金,等. 球囊成形术治疗糖尿病性膝下动脉闭塞症的近中期疗效[J]. 中华普通外科杂志,2014,29(4): 272-275. doi: 10.3760/cma.j.issn.1007-631X.2014.04.009
[12]	王深明,姚陈. 规范下肢动脉硬化闭塞症的血管腔内治疗[J]. 中华外科杂志,2016,54(8): 564-567. doi: 10.3760/cma.j.issn.0529-5815.2016.08.002
[13]	王炜,王爱萍,李晓强. 膝下动脉腔内成形术治疗严重下肢缺血的结果分析[J]. 中华血管外科杂志,2019,4(3): 159-163. doi: 10.3760/cma.j.issn.2096-1863.2019.03.007
[14]	Venkatachalam S,Bunte M,Monteleone P,et al. Combined antegrade-retrograde intervention to improve chronic total occlusion recanalization in high-risk critical limb ischemia[J]. Ann Vasc Surg,2014,28(6): 1439-1448. doi: 10.1016/j.avsg.2014.01.011
[15]	张松,黄梅,殷述刚,等. 膝下动脉逆穿技术在下肢动脉硬化闭塞症中的应用[J]. 齐齐哈尔医学院学报,2020,41(4): 419-421. doi: 10.3969/j.issn.1002-1256.2020.04.009
[16]	蒋俊豪,方超. 下肢动脉血管准备的策略与评估[J]. 中华血管外科杂志,2019,4(3): 138-140. doi: 10.3760/cma.j.issn.2096-1863.2019.03.003
[17]	Cheun TJ,Jayakumar L,Sideman MJ,et al. Outcomes of isolated inframalleolar interventions for chronic limb-threatening ischemia in diabetic patients[J]. J Vasc Surg,2020,71(5): 1644-1652. doi: 10.1016/j.jvs.2019.07.094
[18]	Cheun TJ,Jayakumar L,Ferrer L,et al. Implications of early failure of isolated endovascular tibial interventions[J]. J Vasc Surg,2020,72(1): 233-240. doi: 10.1016/j.jvs.2019.11.035
[19]	Elbadawy A,Ali H,Saleh M,et al. Editor's choice - A prospective study to evaluate complete wound healing and limb salvage rates after angiosome targeted infrapopliteal balloon angioplasty in patients with critical limb ischaemia[J]. Eur J Vasc Endovasc Surg,2018,55(3): 392-397. doi: 10.1016/j.ejvs.2017.12.003
[20]	杨硕菲,张岚. 膝下动脉闭塞腔内治疗热点问题:实践与思考[J]. 介入放射学杂志,2017,26(6): 481-485. doi: 10.3969/j.issn.1008-794X.2017.06.001
[21]	谷涌泉,郭建明. 糖尿病膝下动脉病变腔内治疗的新进展[J]. 中国微创外科杂志,2017,17(4): 289-293. doi: 10.3969/j.issn.1009-6604.2017.04.001
[22]	李炳旻,王芳芳,李倩坤,等. 糖尿病溃疡的发生机制与治疗进展[J]. 解放军医学院学报,2019,40(10): 992-994. doi: 10.3969/j.issn.2095-5227.2019.10.019
[23]	王宁,刘兆玉. 膝下动脉硬化闭塞症介入治疗新进展[J]. 介入放射学杂志,2017,26(2): 188-192. doi: 10.3969/j.issn.1008-794X.2017.02.022
[24]	Hata Y,Iida O,Mano T. Is angiosome-guided endovascular therapy worthwhile?[J]. Ann Vasc Dis,2019,12(3): 315-318. doi: 10.3400/avd.ra.19-00042
[25]	Iida O,Nanto S,Uematsu M,et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia[J]. Catheter Cardiovasc Interv,2010,75(6): 830-836.
[26]	Piaggesi A,Abbruzzese L,Mattaliano C,et al. Sulodexide as adjunctive therapy in diabetic foot patients with critical limb ischemia treated with percutaneous transluminal angioplasty[J]. Int J Low Extrem Wounds,2014,13(2): 103-109. doi: 10.1177/1534734614534442

[1]	YIN Xiangye, CHEN Youbai, HAN Yudi, HAN Yan. Advances in systematic treatment of advanced cutaneous squamous cell carcinoma[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(11): 1276-1279, 1296. DOI: 10.12435/j.issn.2095-5227.2023.083
[2]	WANG Shuo, QIN Xinyuan, GAO Lei, LIU Huanning, WANG Jing, WANG Jiangning. Short-term effect of spinal cord electrical stimulation on peripheral vascular disease in diabetes patients[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(9): 951-955. DOI: 10.12435/j.issn.2095-5227.2023.077
[3]	KANG Xia, YU Jihong, NI Wenfeng, QI Xiaoqin, WANG Shan, DONG Bo, PEI Jinlian, WU Liben, TIAN Yaping, BAI Junbei, CHEN Wei, WANG Yan. Correlation between PPARD rs2267668 and rs1053049 polymorphisms with lower-limb strength in Chinese male exerciser[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2023, 44(8): 897-902. DOI: 10.12435/j.issn.2095-5227.2023.074
[4]	MENG Hao, SU Jianlong, WANG Rui, SHEN Qi, LI Ying, JIANG Yufeng, FU Xiaobing. Clinical epidemiology study of chronic cutaneous wounds: An analysis of 889 inpatients[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2022, 43(3): 253-258. DOI: 10.3969/j.issn.2095-5227.2022.03.003
[5]	ZHI Jia, LI Dongning, ZHENG Song, YANG Yang, ZHAO Fengmei. Expressions of PD-1/PD-L1 in tissues of Bowen's disease and cutaneous squamous cell carcinoma[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2020, 41(6): 628-633. DOI: 10.3969/j.issn.2095-5227.2020.06.018
[6]	ZHANG Zifang, ZHANG Haocong, SONG Kai, YU Yang, WU Yunchang, WANG Zhaohan, WANG Zheng. Effect of percutaneous vertebroplasty/kyphoplasty on adjacent intervertebral disc degeneration[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2018, 39(1): 16-19,27. DOI: 10.3969/j.issn.2095-5227.2018.01.005
[7]	LI Chengfei, WANG Yongchun, SHI Fei, GAO Yuan, SUN Xiqing. Advances in the effects of weightlessness on blood vessels and vascular endothelial cells[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2017, 38(1): 64-67. DOI: 10.3969/j.issn.2095-5227.2017.01.017
[8]	TIAN Liuyang, LIU Yuqi, YANG Meiyan, QIANG Yuwei, LI Yang. Influential factors of early in-stent restenosis in patients with coronary chronic total occlusion after percutaneous coronary intervention[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2016, 37(4): 301-303,307. DOI: 10.3969/j.issn.2095-5227.2016.04.001
[9]	WEI Zhi-cheng, WANG Chun-xi, ZHANG Wei-wei, ZHANG Na, WANG Lu-ning. Opportunity of intestinal surgical resection for acute mesenteric ischemia[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2014, 35(5): 424-426. DOI: 10.3969/j.issn.2095-5227.2014.05.007
[10]	ZENG Wei, YAN Xiao-qing, LIU Dai, YANG Hong-yan, XU Jun. Application of lateral thoracic vessels as alternative recipient vessels in free flap breast reconstruction[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2013, 34(3): 228-230. DOI: 10.3969/j.issn.2095-5227.2013.03.011

Cited By

Get Citation

PDF

XML

Article Metrics

Article views (82) PDF downloads (11)

Midterm outcomes of percutaneous endovascular treatment for below-the-knee chronic total occlusion

Abstract

References

Related Articles

Catalog

Article Metrics

Related

Midterm outcomes of percutaneous endovascular treatment for below-the-knee chronic total occlusion

Abstract

References

Related Articles

Catalog

Article Metrics

Related

Export File

Citation

Format

Content